Ruud began his career in 1986 as a pharma and analytical developer at Pharmachemie, which was acquired by Teva in 1998. Over time, Ruud served as Pharma Development Department project manager and director before being appointed to his current position.
"The move to Teva was a bit nerve-wracking yet very exciting," Ruud says. "Before that, we focused on internal activities within the Netherlands. But as Teva's global presence expanded, I found myself traveling to the US and Israel and being involved in more multinational projects."
As R&D director, Ruud is responsible for R&D in the Netherlands and sterile GR&D in Japan. In addition to generics development, Ruud’s team focuses on innovative development in the Respiratory division, which requires a lot of creative freedom. "We give the employees a lot of freedom of thought. Even if their efforts don’t lead to the end result, it's important for them to experience the work process themselves and learn from it."
While working at Teva can be demanding, Ruud appreciates the challenge. "There's always pressure to deliver, but that's a good thing. The environment is extremely professional, but Teva recognizes the fact that people must also enjoy their work. We're a healthy company with growth opportunities and a great place at which to work."